Bioinformatics analysis of publicly available CRC data sets revealed that transcriptomic expression of MICU2 or the MICU2/MICU1 ratio is correlated with the aggressiveness of CRC, with the highest expression measured in stage IV tumors and in metastases of CRC. The gene discussed is MICU1; the disease is colorectal carcinoma.